Coverage
-
May 18, 2021
Takeda Pharmaceutical unit Baxalta will stop fighting the $173 million in damages it was hit with two years ago for infringing Bayer's patent covering a hemophilia treatment after the two drugmakers managed to work out a deal, a Delaware federal court heard Tuesday.
5 other articles on this case.
View all »